Reuters logo
Genentech, OSI to pay $67 mln over drug claims -U.S. Justice Dept
2016年6月6日 / 晚上9点32分 / 1 年前

Genentech, OSI to pay $67 mln over drug claims -U.S. Justice Dept

WASHINGTON, June 6 (Reuters) - Pharmaceutical companies Genentech and OSI Pharmaceuticals LLC will pay $67 million to resolve allegations they made misleading statements about the effectiveness of the drug Tarceva to treat lung cancer, the U.S. Justice Department said on Monday.

San Francisco-based Genentech and Farmingdale, New York-based OSI Pharmaceuticals co-promoted Tarceva and allegedly made misleading representations to physicians and other healthcare providers about the effectiveness of the drug to treat non-small cell lung cancer, the department said in a statement. (Reporting by Eric Beech; Editing by Mohammad Zargham)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below